Metraipolis › archive › dc_c05023a42ba3
Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single-Dose Phase 1 Study — Europe PMC PMID:41689170
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41689170
- DOI
- 10.1002/cpdd.70036
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T08:44:10.114Z
- SHA-256 of the archived text
200d6c2a4b1062a977e7b50e208400deb9a31429ef416f61a74fb4453261d744- Stable URL of this page
https://metraipolis.com/documento/dc_c05023a42ba3
How to cite
Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single-Dose Phase 1 Study — Europe PMC PMID:41689170 — Europe PMC (en), https://europepmc.org/article/MED/41689170 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c05023a42ba3 (Metraipolis archive dc_c05023a42ba3, sha256 200d6c2a4b1062a977e7b50e208400deb9a31429ef416f61a74fb4453261d744)
BibTeX
@misc{dcc05023a42ba3,
title = {Effect of Renal Impairment on the Pharmacokinetics and Safety of Doxecitine and Doxribtimine: A Single-Dose Phase 1 Study — Europe PMC PMID:41689170},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41689170},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c05023a42ba3; sha256 200d6c2a4b1062a977e7b50e208400deb9a31429ef416f61a74fb4453261d744},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41689170. Agents can read the archived copy with the MCP tool read_document.